Effect of psychotherapy on the course of crohn's disease: Results of the German prospective multicenter psychotherapy treatment study on Crohn's disease

Scandinavian Journal of Gastroenterology

Volumn 33, Issue 12, 1998, Pages 1289-1296

  Jantschek, Günter ^a   Zeitz, M ^b   Pritsch, M ^b   Wirsching, M ^b   Klor H U ^b   Studt, H H ^b   Rasenack, J ^b   Deter, H C ^b   Riecken, E O ^b   Feiereis, H ^b   Keller, W ^b  

^a UNIVERSITY OF LÜBECK   (Germany)

^b NONE

Author keywords

Anxiety; Corticosteroids; Crohn's disease; Depression; Outcome study; Psychodynamic psychotherapy; Quality of life

Indexed keywords

CORTICOSTEROID;

ADOLESCENT; ADULT; AGED; ANXIETY NEUROSIS; ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; CROHN DISEASE; DEPRESSION; FEMALE; GASTROINTESTINAL DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; PSYCHOTHERAPY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANTI-INFLAMMATORY AGENTS; COMBINED MODALITY THERAPY; CROHN DISEASE; FEMALE; GLUCOCORTICOIDS; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PSYCHOTHERAPY; QUALITY OF LIFE; STEROIDS;

EID: 0032446384     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365529850172386     Document Type: Article

References (40)

1. Farmer RG, Whelan G, Fazio UW. Long-term follow-up of patients with Crohn's disease. Gastroenterolgy 1985;88:1818-25.
2. Lind E, Fausa O, Gjone E, Mogensen SB. Crohn's disease. Treatment and outcome. Scand J Gastroenterol 1985;20:1014-8.
3. Binder CV, Hendriksen C, Kreiner S. Prognosis in Crohn's disease - based on results from a regional patient group from the county of Copenhagen. Gut 1985;26:146-50.
4. Harper PH, Fazio VW, Lavery IC, Jagelman DG, Weakley FL, Farmer RG, et al. The long-term outcome in Crohn's disease. Dis Colon Rectum 1987;30:174-9.
5. Sachar DB. The problem of postoperative recurrence of Crohn's disease. Med Clin North Am 1990;74:183.
6. Halme LE. Results of surgical treatment of patients with Crohn's disease. Ann Chir Gynaecol 1992;81:277-83.
7. Nordgren SR, Fasth SB, Öresland TO, Hulten LA. Long-term follow-up in Crohn's disease. Mortality, morbidity, and functional status. Scand J Gastroenterol 1994;29:1122-8.
8. Drossmann DA, Patrick DL, Mitchell CM, Zagami EA, Appelbaum MI. Health-related quality of life in inflammatory bowel disease - functional status and patient's worries and concerns. Dig Dis Sci 1989;34:1379-86.
9. Ford CV, Golder GA, Castelnuovo-Tedesco P. A psychiatric study of patients with regional enteritis. JAMA 1969;208:311-5.
10. Whybrow PC, Kane FJ, Lipton MA. Regional ileitis and psychiatric disorder. Psychosom Med 1968;30:209-21.
11. McKegney FP, Gordon RO, Levine SM. A psychosomatic comparison of patients with ulcerative colitis and Crohn's disease. Psychosom Med 1970;32:153-66.
12. Latimer PR. Crohn's disease: a review of the psychological and social outcome. Psychol Med 1978;8:649-56.
13. Gerbert B. Psychological aspects of Crohn's disease. J Behav Med 1980;3:41-58.
14. Helzer JE, Chammas S, Norland CC, Stillings WA, Alpers DH. A study of the association between Crohn's disease and psychiatric illness. Gastroenterology 1984;86:324-30.
15. Feiereis H, Jantschek G. Morbus Crohn. In: Uexküll T, Adler R, Herrmann JM, Köhle K, Schonecke OW, Wesiak W, editors. Psychosomatische Medizin. 5th ed. Munich: Urban & Schwarzenberg; 1996, p. 853-66.
16. North CS, Alpers DH, Helzer JE, Spitznagel EL, Clouse RE. Do life events or depression exacerbate inflammatory bowel disease? A prospective study. Ann Intern Med 1991;114:381-6.
17. von-Wietersheim J, Köhler T, Feiereis H. Relapse-precipitating life events and feelings in patients with inflammatory bowel disease. Psychother Psychosom 1992;58:103-12.
18. Drossman DA. The role of psychosocial factors. In: Schölmerich J, Goebell H, Kruis W, Hohenberger W, Gross V, editors. Inflammatory bowel diseases: pathophysiology as basis of treatment. Lancaster: Kluwer; 1993, p. 19-29.
19. Andrews H, Barczak P, Allan RN. Psychiatric illness in patients with inflammatory bowel disease. Gut 1987;28:1600-4.
20. Paulley JW. Crohn's disease: treatment by corticosteroids, antibiotics and psychotherapy. Psychother Psychosom 1971;19: 111-7.
21. Paulley JW. Psychological management of Crohn's disease. Practitioner 1974;213:59-64.
22. Milne B, Joachim G, Niedhardt J. A stress management programme for inflammatory bowel disease patients. J Adv Nurs 1986;11:561-7.
23. Schwarz SP, Blanchard EB. Evaluation of a psychological treatment for inflammatory bowel disease. Behav Res Ther 1991;29:167-77.
24. Künsebeck HW, Lempa W, Freyberger H. Kurz- und Langzeiteffekte ergänzender Psychotherapie bei Patienten mit Morbus Crohn. In: Lamprecht F, editor. Spezialisierung und Integration in Psychosomatik und Psychotherapie. Berlin: Springer; 1987, p. 253-62.
25. Best WR, Becktel JM, Singleton JW, Kern F. Development of a Crohn's Disease Activity Index. Gastroenterology 1976;70:439-44.
26. Malchow H, Ewe K, Brandes JW, Goebell H, Ehms H, Sommer H, et al. European cooperative Crohn's disease study (ECCDS): results of drug treatment. Gastroenterology 1984;86:249-66.
27. Luborsky L Principles of psychoanalytic psychotherapy. New York: Basic Books; 1984.
28. Beck AT, Ward C, Medelson M, Mock F, Erbaugh F. An inventory of measuring depression. Arch Gen Psychiat 1961; 4:561-71.
29. Spielberger CD, Gorsuch RL, Lushene RE. Manual for the state-trait anxiety inventory. Palo Alto (CA): Consulting Psychologist Press; 1970.
30. Heinisch M, Ludwig M, Bullinger M. Psychometrische Testung der Münchner Lebensqualität Dimensionen Liste (MLDL). In: Bullinger M, Ludwig M, Steinbüchel NV, editors. Lebensqualität bei kardiovaskulären Erkrankungen. Göttingen: Hogrefe; 1991, p. 73-90.
31. Rudolf G. Untersuchung und Befund bei Neurosen und psychosomatischen Erkrankungen. Materialien zum 'Psychischen und Sozialkommunikativen Befund' (PSKB). Weinheim: Beltz; 1981.
32. Hellers G. Crohn's disease in Stockholm county 1955-1974. A study of epidemiology, results of surgical treatment and long term prognosis. Acta Chir Scand 1979;Suppl 490:1-84.
33. Binder V. Epidemiology, course and socio-economic influence of inflammatory bowel disease. Schweiz Med Wochenschr 1988;118:738-42.
34. Salomon P, Kornbluth A, Aisenberg J, Janowitz AD. How effective are our current drugs for Crohn's disease? A metaanalysis. J Clin Gastroenterol 1992;14:211.
35. Sachar DB. Budenoside for inflammatory bowel disease. Is it a magic bullet? [editorial]. N Engl J Med 1994;331:873-4.
36. Rutgeerts P, Löfberg R, Malchow H, Lamers C, Olaison G, Jewell D, et al. A comparison of budenoside with prednisolone for active Crohn's disease. N Engl J Med 1994;331:842-5.
37. Myren J, Bouchier IAD, Watkinson G, Softley A, Clamp SE, de Dombal FT. The OMGE multinational inflammatory bowel disease survey 1976-1986. Scand J Gastroenterol 1988;23 Suppl 144:11-9.
38. Mitchell A, Guyatt G, Singer J, Irvine EJ, Goodacre R, Tompkins C, et al. Quality of life in patients with inflammatory bowel disease. J Clin Gastroenterol 1988;10:306-10.
39. Hoglen P. Motivation for brief dynamic psychotherapy. Psychother Psychosom 1996;65:209-15.
40. Orlinsky DE, Grawe K, Parks BK. Process and outcome in psychotherapy. In: Garfield SL, Bergin AE, editors. Handbook of psychotherapy and behaviour change, 4th ed. New York: Wiley; 1994, p. 270-376.